Robert Burns
Stock Analyst at H.C. Wainwright
(4.50)
# 1,126
Out of 5,189 analysts
1108
Total ratings
36.6%
Success rate
9.8%
Average return
Main Sectors:
Stocks Rated by Robert Burns
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PMVP PMV Pharmaceuticals | Reiterated: Buy | $5 | $0.876 | +470.78% | 25 | Nov 20, 2026 | |
| ORIC ORIC Pharmaceuticals | Reiterated: Buy | $27 → $20 | $7.36 | +171.74% | 51 | Nov 19, 2026 | |
| PRLD Prelude Therapeutics | Reiterated: Buy | $8 | $3.23 | +147.68% | 27 | Nov 18, 2026 | |
| CGEM Cullinan Therapeutics | Reiterated: Buy | $35 | $8.89 | +293.70% | 15 | Nov 17, 2026 | |
| HURA TuHURA Biosciences | Reiterated: Buy | $10 | $1.25 | +700.00% | 10 | Nov 17, 2026 | |
| NUVB Nuvation Bio | Reiterated: Buy | $21 | $3.80 | +452.63% | 36 | Nov 17, 2026 | |
| RVMD Revolution Medicines | Reiterated: Buy | $350 | $161.20 | +117.12% | 49 | Nov 17, 2026 | |
| BLSM BlossomHill Therapeutics | Reiterated: Buy | $35 | $14.51 | +141.21% | 4 | Nov 16, 2026 | |
| CRDF Cardiff Oncology | Reiterated: Buy | $9 | $0.8528 | +955.35% | 15 | Nov 16, 2026 | |
| IMMX Immix Biopharma | Reiterated: Buy | $25 → $27 | $6.96 | +287.93% | 17 | Nov 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $245 → $220 | $68.97 | +218.98% | 3 | Nov 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $73 | $46.53 | +56.89% | 14 | Nov 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $27.44 | +45.77% | 3 | Nov 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 → $36 | $8.44 | +326.54% | 15 | Nov 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $1.31 | +739.69% | 44 | Nov 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 | $10.52 | +156.65% | 22 | Nov 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $130 → $110 | $80.96 | +35.87% | 105 | Nov 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 → $21 | $1.45 | +1,348.28% | 18 | Nov 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $68 → $67 | $21.73 | +208.33% | 25 | Nov 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 → $56 | $26.14 | +114.23% | 47 | Nov 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 → $56 | $26.72 | +109.62% | 30 | Nov 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 | $16.12 | +79.90% | 37 | Nov 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $34 | $2.14 | +1,488.79% | 8 | Nov 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $36 | $12.85 | +180.16% | 33 | Nov 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $56 → $78 | $64.63 | +20.69% | 26 | Nov 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $2.53 | +414.85% | 8 | Nov 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.2843 | - | 31 | Oct 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $8.37 | +138.95% | 2 | Sep 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $3 | $0.025 | +11,900.00% | 1 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 → $21 | $2.70 | +677.78% | 8 | Jul 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $0.919 | +661.70% | 23 | Jul 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1.28 | - | 45 | Jun 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $16 | $0.6304 | +2,438.07% | 1 | Jun 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $33 → $35 | $16.15 | +116.72% | 3 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $0.7538 | +1,624.60% | 10 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $4.91 | +42.57% | 4 | May 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1.96 | - | 34 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 | $1.81 | +1,502.21% | 7 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $3.07 | - | 23 | Apr 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $11 | $0.6277 | +1,652.43% | 32 | Apr 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $19.07 | - | 44 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $0.9073 | +781.74% | 12 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $6.33 | n/a | 29 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $15.54 | n/a | 8 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0002 | n/a | 6 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.96 | n/a | 19 | May 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $110 → $20 | $0.4775 | n/a | 2 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $2.10 | n/a | 13 | Jan 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $22.15 | n/a | 18 | Mar 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $3.92 | n/a | 7 | Mar 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $2.03 | n/a | 15 | May 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $1.64 | n/a | 16 | Oct 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $0.7495 | n/a | 8 | Mar 5, 2021 |
PMV Pharmaceuticals
Nov 20, 2026
Reiterated: Buy
Price Target: $5
Current: $0.876
Upside: +470.78%
ORIC Pharmaceuticals
Nov 19, 2026
Reiterated: Buy
Price Target: $27 → $20
Current: $7.36
Upside: +171.74%
Prelude Therapeutics
Nov 18, 2026
Reiterated: Buy
Price Target: $8
Current: $3.23
Upside: +147.68%
Cullinan Therapeutics
Nov 17, 2026
Reiterated: Buy
Price Target: $35
Current: $8.89
Upside: +293.70%
TuHURA Biosciences
Nov 17, 2026
Reiterated: Buy
Price Target: $10
Current: $1.25
Upside: +700.00%
Nuvation Bio
Nov 17, 2026
Reiterated: Buy
Price Target: $21
Current: $3.80
Upside: +452.63%
Revolution Medicines
Nov 17, 2026
Reiterated: Buy
Price Target: $350
Current: $161.20
Upside: +117.12%
BlossomHill Therapeutics
Nov 16, 2026
Reiterated: Buy
Price Target: $35
Current: $14.51
Upside: +141.21%
Cardiff Oncology
Nov 16, 2026
Reiterated: Buy
Price Target: $9
Current: $0.8528
Upside: +955.35%
Immix Biopharma
Nov 16, 2026
Reiterated: Buy
Price Target: $25 → $27
Current: $6.96
Upside: +287.93%
Nov 16, 2026
Reiterated: Buy
Price Target: $245 → $220
Current: $68.97
Upside: +218.98%
Nov 13, 2026
Reiterated: Buy
Price Target: $73
Current: $46.53
Upside: +56.89%
Nov 13, 2026
Reiterated: Buy
Price Target: $40
Current: $27.44
Upside: +45.77%
Nov 11, 2026
Reiterated: Buy
Price Target: $42 → $36
Current: $8.44
Upside: +326.54%
Nov 11, 2026
Reiterated: Buy
Price Target: $11
Current: $1.31
Upside: +739.69%
Nov 10, 2026
Reiterated: Buy
Price Target: $27
Current: $10.52
Upside: +156.65%
Nov 10, 2026
Reiterated: Buy
Price Target: $130 → $110
Current: $80.96
Upside: +35.87%
Nov 10, 2026
Reiterated: Buy
Price Target: $23 → $21
Current: $1.45
Upside: +1,348.28%
Nov 10, 2026
Reiterated: Buy
Price Target: $68 → $67
Current: $21.73
Upside: +208.33%
Nov 10, 2026
Reiterated: Buy
Price Target: $55 → $56
Current: $26.14
Upside: +114.23%
Nov 9, 2026
Reiterated: Buy
Price Target: $55 → $56
Current: $26.72
Upside: +109.62%
Nov 9, 2026
Reiterated: Buy
Price Target: $29
Current: $16.12
Upside: +79.90%
Nov 6, 2026
Reiterated: Buy
Price Target: $34
Current: $2.14
Upside: +1,488.79%
Nov 5, 2026
Reiterated: Buy
Price Target: $36
Current: $12.85
Upside: +180.16%
Nov 2, 2026
Reiterated: Buy
Price Target: $56 → $78
Current: $64.63
Upside: +20.69%
Nov 2, 2026
Reiterated: Buy
Price Target: $13
Current: $2.53
Upside: +414.85%
Oct 8, 2026
Downgraded: Hold
Price Target: n/a
Current: $0.2843
Upside: -
Sep 30, 2026
Reiterated: Buy
Price Target: $20
Current: $8.37
Upside: +138.95%
Jul 31, 2026
Downgraded: Hold
Price Target: $3
Current: $0.025
Upside: +11,900.00%
Jul 20, 2026
Reiterated: Buy
Price Target: $27 → $21
Current: $2.70
Upside: +677.78%
Jul 9, 2026
Reiterated: Buy
Price Target: $7
Current: $0.919
Upside: +661.70%
Jun 8, 2026
Downgraded: Hold
Price Target: n/a
Current: $1.28
Upside: -
Jun 4, 2026
Initiated Coverage: Buy
Price Target: $16
Current: $0.6304
Upside: +2,438.07%
Jun 3, 2026
Rated: Buy
Price Target: $33 → $35
Current: $16.15
Upside: +116.72%
Jun 1, 2026
Reiterated: Buy
Price Target: $13
Current: $0.7538
Upside: +1,624.60%
May 28, 2026
Reiterated: Buy
Price Target: $7
Current: $4.91
Upside: +42.57%
May 7, 2026
Reiterated: Hold
Price Target: n/a
Current: $1.96
Upside: -
May 1, 2026
Reiterated: Buy
Price Target: $29
Current: $1.81
Upside: +1,502.21%
Apr 21, 2026
Reiterated: Hold
Price Target: n/a
Current: $3.07
Upside: -
Apr 16, 2026
Reiterated: Buy
Price Target: $8 → $11
Current: $0.6277
Upside: +1,652.43%
Apr 13, 2026
Downgraded: Sell
Price Target: n/a
Current: $19.07
Upside: -
Feb 13, 2026
Reiterated: Buy
Price Target: $8
Current: $0.9073
Upside: +781.74%
Aug 19, 2025
Reiterated: Hold
Price Target: n/a
Current: $6.33
Upside: n/a
Sep 3, 2024
Rated: Hold
Price Target: n/a
Current: $15.54
Upside: n/a
Jul 16, 2024
Rated: Hold
Price Target: n/a
Current: $0.0002
Upside: n/a
May 24, 2024
Rated: Hold
Price Target: n/a
Current: $2.96
Upside: n/a
Mar 21, 2024
Reiterated: Buy
Price Target: $110 → $20
Current: $0.4775
Upside: n/a
Jan 8, 2024
Downgraded: Hold
Price Target: n/a
Current: $2.10
Upside: n/a
Mar 21, 2023
Reiterated: Hold
Price Target: n/a
Current: $22.15
Upside: n/a
Mar 17, 2023
Reiterated: Buy
Price Target: $22
Current: $3.92
Upside: n/a
May 10, 2022
Reiterated: Buy
Price Target: $11
Current: $2.03
Upside: n/a
Oct 22, 2021
Reiterated: Sell
Price Target: n/a
Current: $1.64
Upside: n/a
Mar 5, 2021
Reiterated: Buy
Price Target: $10
Current: $0.7495
Upside: n/a